ClinicalTrials.Veeva

Menu

Real-world Effect of Switching From Intermittently-scanned to Real-time Continuous Glucose Monitoring (Switch CGM Retro)

L

LMC Diabetes & Endocrinology Ltd.

Status

Completed

Conditions

Diabetes Mellitus

Treatments

Device: real-time continuous glucose monitor

Study type

Observational

Funder types

Other
Industry

Identifiers

NCT06962735
Switch CGM retro

Details and patient eligibility

About

The objective of this retrospective, observational study, is to better understand the real-world glycemic effectiveness of switching to real time continuous glucose monitoring (rtCGM) from intermittently scanned continuous glucose monitoring (isCGM) among adults with type 1 diabetes or type 2 diabetes in Canada.

Enrollment

220 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • 18 years or older as of the index date
  • Clinical diagnosis of T1D or T2D ≥ one year
  • Using either MDI or CSII therapy
  • Initiated a FreeStyle Libre® isCGM device between January 1, 2018 and July 31, 2023 (isCGM cohort)
  • Switched from a FreeStyle Libre® 1 or Libre 2® isCGM device to a Dexcom® G5 or G6 CGM device between April 1, 2018 and July 31, 2023 (rtCGM cohort)
  • Baseline HbA1c ≥7.0% for primary objective with rtCGM cohort
  • Baseline HbA1c ≥8.0% for key secondary objective comparing rtCGM cohort to isCGM cohort
  • Known rtCGM/isCGM start date (month and year)
  • Exclusive use of isCGM for ≥ 3 months
  • ≥ one HbA1c value up to 6 months (± 6 weeks) prior to index date (HbA1c value must be after isCGM initiation and no more than 6 weeks after the index date)
  • ≥ one HbA1c value 6-12 months (± 6 weeks) following the index date
  • Informed consent for their medical record data to be used for research purposes

Exclusion criteria

  • Have a prior history of rtCGM within 12 months of the index date
  • Are pregnant at the time of isCGM initiation or time of switch to rtCGM
  • Used the isCGM or rtCGM for < 3 months

Trial design

220 participants in 2 patient groups

real-time continuous glucose monitoring switch group (rtCGM switch group)
Description:
adults with diabetes that switched from an isCGM to an rtCGM
Treatment:
Device: real-time continuous glucose monitor
intermittently scanned continuous glucose monitoring group (isCGM group)
Description:
adults with diabetes that remained on an isCGM

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems